Antimalarial pharmacokinetics and treatment regimens.

Antimalarial pharmacokinetics and treatment regimens.

Bibliographic Details
Main Author:	White, N
Format:	Journal article
Language:	English
Published:	1992

Similar Items

Clinical pharmacokinetics of antimalarial drugs.
by: White, N
Published: (1985)

CLINICAL IMPORTANCE OF ANTIMALARIAL PHARMACOKINETICS
by: Karbwang, J, et al.
Published: (1988)

Antimalarial dosing regimens and drug resistance.
by: Barnes, K, et al.
Published: (2008)

Pharmacokinetic and pharmacodynamic considerations in antimalarial dose optimization.
by: White, N
Published: (2013)

Pharmacokinetic determinants of the window of selection for antimalarial drug resistance.
by: Stepniewska, K, et al.
Published: (2008)

Pharmacokinetic evaluation and metabolite characterization of the antimalarial piperaquine in the rat
by: Tarning, J, et al.
Published: (2007)

Mefloquine antimalarial prophylaxis in pregnancy: dose finding and pharmacokinetic study.
by: Nosten, F, et al.
Published: (1990)

An overview of pharmacokinetics of antimalarial drugs in the treatment of pregnant women with uncomplicated malaria
by: Lindegardh, N
Published: (2011)

POPULATION PHARMACOKINETICS OF ANTIMALARIAL DRUGS IN THE TREATMENT OF PREGNANT WOMEN WITH UNCOMPLICATED MALARIA
by: Tarning, J, et al.
Published: (2010)

Pharmacokinetics and metabolism of the antimalarial piperaquine after intravenous and oral single doses to the rat.
by: Tarning, J, et al.
Published: (2008)

Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance.
by: Ward, SA, et al.
Published: (2007)

Pharmacokinetics and pharmacodynamics of antimalarial drugs in pregnant women
by: Kloprogge, F
Published: (2013)

The clinical evaluation of antimalarial treatment response.
by: White, N
Published: (1991)

Enantiospecific pharmacokinetics and drug-drug interactions of primaquine and blood-stage antimalarial drugs
by: Chairat, K, et al.
Published: (2018)

Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand.
by: Tarning, J, et al.
Published: (2014)

Population pharmacokinetics and antimalarial pharmacodynamics of piperaquine in patients with plasmodium vivax malaria in Thailand
by: Tarning, J, et al.
Published: (2014)

Pharmacokinetic analysis of new synthetic antimalarial N-251
by: Kazuaki Okada, et al.
Published: (2019-07-01)

Why is it that antimalarial drug treatments do not always work?
by: White, N
Published: (1998)

Antimalarial drug resistance
by: White, N
Published: (2004)

Cardiotoxicity of antimalarial drugs.
by: White, N
Published: (2007)

Antimalarial drug resistance.
by: White, N
Published: (2004)

Cardiac effects of antimalarial treatment with halofantrine.
by: Nosten, F, et al.
Published: (1993)

How antimalarial drug resistance affects post-treatment prophylaxis.
by: White, N
Published: (2008)

Population pharmacokinetics of the antimalarial amodiaquine: A pooled analysis to optimize dosing
by: Ali, A, et al.
Published: (2018)

Estimation of Pediatric Dosage of Antimalarial Drugs, Using Pharmacokinetic and Physiological Approach
by: Ellen K. G. Mhango, et al.
Published: (2023-03-01)

Effects of Surface Characteristics of Polymeric Nanocapsules on the Pharmacokinetics and Efficacy of Antimalarial Quinine
by: Michels LR, et al.
Published: (2019-12-01)

Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum.
by: Barnes, K, et al.
Published: (2005)

The assessment of antimalarial drug efficacy.
by: White, N
Published: (2002)

Loading dose in antimalarial prophylaxis.
by: White, N
Published: (1985)

Medication adherence framework: A population‐based pharmacokinetic approach and its application in antimalarial treatment assessments
by: Junjie Ding, et al.
Published: (2024-05-01)

Population pharmacokinetic assessment of a new regimen of mefloquine used in combination treatment of uncomplicated falciparum malaria.
by: Ashley, E, et al.
Published: (2006)

SCHIZONTOCIDAL ANTIMALARIALS - A REPLY
by: White, N, et al.
Published: (1990)

The threat of antimalarial drug resistance
by: Hanboonkunupakarn, B, et al.
Published: (2016)

Use of population pharmacokinetic‐pharmacodynamic modelling to inform antimalarial dose optimization in infants
by: Banda, CG, et al.
Published: (2024)

Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children.
by: Liusheng Huang, et al.
Published: (2017-01-01)

Pharmacokinetic evaluation of Chalcone derivatives with antimalarial activity in New Zealand White Rabbits
by: Shweta Sinha, et al.
Published: (2021-07-01)

Antimalarial drug resistance: the pace quickens.
by: White, N
Published: (1992)

No evidence of cardiotoxicity during antimalarial treatment with artemether-lumefantrine.
by: van Vugt, M, et al.
Published: (1999)

How antimalarial drug resistance affects post-treatment prophylaxis
by: White Nicholas J
Published: (2008-01-01)

Antimalarial drug toxicity: a review.
by: Taylor, W, et al.
Published: (2004)